| Metastasis-directed Therapy for Oligorecurrent Prostate Cancer (NCT05352178) | Universitaire Ziekenhuizen KU Leuven | 2022-04-20 |
| COAST Therapy in Advanced Solid Tumors and Prostate Cancer (NCT05036226) | Medical University of South Carolina | 2022-03-03 |
| Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer (NCT04742361) | ABX advanced biochemical compounds GmbH | 2021-08-27 |
| MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer (NCT04876755) | Matrix Biomed, Inc. | 2021-05-30 |
| An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum (NCT05384002) | Fondazione del Piemonte per l'Oncologia | 2021-02-24 |
| Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (NCT04641078) | University Hospital, Ghent | 2021-02-12 |
| PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (NCT05022914) | Azienda Ospedaliero-Universitaria Careggi | 2021-01-19 |
| Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. (NCT04644822) | Centre for Probe Development and Commercialization | 2020-12-21 |
| Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer (NCT04686188) | Institute of Cancer Research, United Kingdom | 2020-11-26 |
| Molecular Profiling in Prostate Cancer (NCT04983628) | Hellenic Cooperative Oncology Group | 2020-10-01 |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer (NCT04428203) | Zin W Myint | 2020-08-03 |
| A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer (NCT04734184) | Curium PET France | 2020-07-07 |
| Identification of Predictive Biomarkers (NCT04324983) | Martini-Klinik am UKE GmbH | 2020-03-01 |
| F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer (NCT04239742) | Radboud University Medical Center | 2020-01-02 |
| Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer (NCT04011410) | Patrick Hensley | 2019-12-03 |
| Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (NCT04114825) | RhoVac APS | 2019-11-19 |
| The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer (NCT04134130) | Lund University | 2019-09-16 |
| F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence (NCT04102553) | ABX advanced biochemical compounds GmbH | 2019-03-06 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (NCT03739684) | Progenics Pharmaceuticals, Inc. | 2018-11-27 |
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer (NCT03444844) | Five Eleven Pharma, Inc. | 2018-05-10 |
| Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (NCT03396874) | University of Michigan | 2018-02-09 |
| HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer (NCT03553602) | Loyola University | 2017-12-20 |
| Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer (NCT03329742) | Indiana University | 2017-12-19 |
| Evaluation of the Metastasis and Recurrence of Prostate Cancer (NCT03507595) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2017-09-01 |
| Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer (NCT03443609) | Institut Cancerologie de l'Ouest | 2017-03-31 |
| Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy (NCT02974075) | Medical University of Vienna | 2016-08-01 |
| PET-MR-PSA Prostate Cancer Recidive Study (NCT02562131) | Norwegian University of Science and Technology | 2015-09-01 |
| Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer (NCT02560181) | Sunnybrook Health Sciences Centre | 2014-08-01 |
| Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer (NCT01938339) | Seoul National University Hospital | 2012-05-01 |
| Firmagon (Degarelix) Intermittent Therapy (NCT01512472) | Canadian Urology Research Consortium | 2012-01-01 |
| Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanningâ„¢ and MRI (NCT01857037) | Hospices Civils de Lyon | 2011-05-01 |
| SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience (NCT03604211) | Kantonsspital Graubuenden | 2010-01-01 |
| Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer (NCT04452136) | Jeanne Link | |
| Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer (NCT05002465) | Dana Mathews | |